INDP

Indaptus Therapeutics (INDP)

About Indaptus Therapeutics (INDP)

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.

Details

Daily high
$0.84
Daily low
$0.78
Price at open
$0.84
52 Week High
$3.10
52 Week Low
$0.78
Market cap
9.6M
Dividend yield
0.00%
Volume
24,229
Avg. volume
24,918
P/E ratio
-.46

Indaptus Therapeutics News

Details

Daily high
$0.84
Daily low
$0.78
Price at open
$0.84
52 Week High
$3.10
52 Week Low
$0.78
Market cap
9.6M
Dividend yield
0.00%
Volume
24,229
Avg. volume
24,918
P/E ratio
-.46